Time For Independent US FDA? COVID Political Pressure Reignites Debate

The political spotlight on the FDA during the coronavirus pandemic has renewed a long-standing debate as to whether it should be made an independent, Cabinet-level federal agency and freed from direct HHS oversight.

USA map
• Source: Shutterstock

The argument for an independent US Food and Drug Administration (FDA) has taken on renewed interest following President Trump’s political pressure on the agency to rapidly clear COVID-19 products, most notably a vaccine. But while the idea of a more independent agency enjoys broad stakeholder support, it is far from universal, and practical considerations suggest that the FDA will always face a fair degree of oversight by elected officials.

Still, it remains the hope of many – especially former commissioners who have sat in the political hotseat – that...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Market Intelligence

More from In Vivo